Biological E Gets CDSCO Panel Nod To Study Inactivated Poliomyelitis Vaccine
New Delhi: Vaccine major Biological E has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to conduct the Phase III clinical trial of Biological E's inactivated poliomyelitis vaccine, administered to 6-8 weeks old healthy infants in 6-10-14 weeks dosing schedule.
This came after the firm presented a Phase II study report along with a Phase III clinical trial Protocol,titled, “A single blind, randomized, active-controlled, Phase Ill study to valuate immunogenicity and safety of Biological E's inactivated poliomyelitis vaccine, administered to 6-8 weeks old healthy infants in 6-10-14 weeks dosing schedule.”
The committee noted the results from the Phase II clinical trial report. The inactivated poliovirus vaccine (IPV) is a vaccine that protects against poliovirus types 1, 2, and 3.
Polio is an illness caused by a virus that mainly affects nerves in the spinal cord or brain stem. In its most severe form, polio can lead to a person being unable to move certain limbs, also called paralysis. It can also lead to trouble breathing and sometimes death. The disease is also called poliomyelitis.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.